M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule
Status:
Completed
Trial end date:
2017-12-06
Target enrollment:
Participant gender:
Summary
This is a Phase I study consisting of 2 parts: Part 1 aims to investigate the relative
bioavailability of tablet formulation (test treatment) and Powder in capsule (PiC)
formulation (reference treatment) of M7583 under fasted conditions. The aim of Part 2 is to
determine and compare the single dose Pharmacokinetic (PK) profile of M7583 tablet under
fasted and fed conditions to assess the food effect.